or Try an Advanced Search...

    Technical Analysis for VRCA - Verrica Pharmaceuticals Inc.

    Grade Last Price % Change Price Change
    F 1.53 9.29% 0.13
    VRCA closed up 9.29 percent on Friday, November 1, 2024, on 52 percent of normal volume.
    Earnings due: Nov 7
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical VRCA trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Fell Below 20 DMA Bearish 9.29%
    New Downtrend Bearish 9.29%
    Wide Bands Range Expansion 9.29%
    Stochastic Reached Overbought Strength -4.38%
    Weak + Overbought Other -4.38%
    Wide Bands Range Expansion -4.38%
    Older End-of-Day Signals for VRCA ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 20 DMA about 19 hours ago
    10 DMA Resistance about 19 hours ago
    Possible Pocket Pivot about 19 hours ago
    Possible Inside Day about 19 hours ago
    Up 10% about 19 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    VRCA Chart by TradingView
    Basic chart:

    Profile

    Verrica is a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs. The company’s lead product candidate, VP-102, is currently being evaluated in two Phase 3 clinical trials for the treatment of molluscum and in a Phase 2 clinical trial for the treatment of common warts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical Medication Pharmaceutical Products Clinical Trial Skin Diseases Treatment Of Skin Diseases Common Warts

    Is VRCA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 9 Verrica Pharmaceuticals Inc (VRCA) Q2 2024 Earnings Call Highlights: Revenue Growth Amid Rising ...
    Oct 3 Verrica downgraded to hold by Needham, cash position cited
    Oct 3 This Tractor Supply Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
    Oct 2 Verrica Pharmaceuticals reports restructuring of commercial organization
    Oct 2 Verrica Pharmaceuticals Announces Restructuring of Commercial Organization
    Sep 29 Verrica Pharmaceuticals Inc. (VRCA): Worst 52-Week Low Stock to Buy Now
    Sep 25 Is Verrica Pharmaceuticals Inc. (VRCA) The Worst 52-Week Low Stocks to Buy Now According to Short Sellers?
    Sep 4 Verrica Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference in New York
    Sep 1 Wall Street Breakfast: The Week Ahead
    Aug 27 Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month
    See more VRCA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.4
    52 Week Low 1.0404
    Average Volume 928,745
    200-Day Moving Average 5.36
    50-Day Moving Average 1.75
    20-Day Moving Average 1.47
    10-Day Moving Average 1.55
    Average True Range 0.17
    RSI (14) 45.65
    ADX 27.02
    +DI 18.09
    -DI 23.48
    Chandelier Exit (Long, 3 ATRs) 1.24
    Chandelier Exit (Short, 3 ATRs) 1.60
    Upper Bollinger Bands 1.70
    Lower Bollinger Band 1.23
    Percent B (%b) 0.63
    BandWidth 31.77
    MACD Line -0.09
    MACD Signal Line -0.15
    MACD Histogram 0.0528
    Fundamentals Value
    Market Cap 64.36 Million
    Num Shares 42.1 Million
    EPS -1.08
    Price-to-Earnings (P/E) Ratio -1.42
    Price-to-Sales 72.34
    Price-to-Book 5.47
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.75
    Resistance 3 (R3) 1.73 1.64 1.71
    Resistance 2 (R2) 1.64 1.59 1.65 1.70
    Resistance 1 (R1) 1.59 1.55 1.62 1.60 1.69
    Pivot Point 1.50 1.50 1.51 1.51 1.50
    Support 1 (S1) 1.44 1.44 1.47 1.46 1.37
    Support 2 (S2) 1.35 1.41 1.36 1.36
    Support 3 (S3) 1.30 1.35 1.35
    Support 4 (S4) 1.31